UB Paderborn / Katalog / Suche / in CDI

Culture and health

The Lancet (British edition), 2014-11, Vol.384 (9954), p.1607-1639

2014

Link zum Volltext

Verfügbarkeit prüfen

Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial

The Lancet (British edition), 2020-02, Vol.395 (10225), p.698-708

2020

Link zum Volltext

Verfügbarkeit prüfen

Racism and the Life Course: Taking Time Seriously

American journal of public health (1971), 2019-01, Vol.109 (S1), p.S43-S47

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

The Lancet (British edition), 2013-08, Vol.382 (9894), p.780-789

2013

Link zum Volltext

Verfügbarkeit prüfen

Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial

The Lancet (British edition), 2013-02, Vol.381 (9864), p.375-384

2013

Link zum Volltext

Verfügbarkeit prüfen

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

The Lancet (British edition), 2015, Vol.385 (9963), p.117-171

2015

Link zum Volltext

Verfügbarkeit prüfen

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

The Lancet (British edition), 2021-06, Vol.397 (10293), p.2476-2486

2021

Link zum Volltext

Verfügbarkeit prüfen

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

The Lancet (British edition), 2019-09, Vol.394 (10202), p.919-928

2019

Link zum Volltext

Verfügbarkeit prüfen

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-02, Vol.391 (10121), p.668-678

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

The Lancet (British edition), 2021-04, Vol.397 (10282), p.1351-1362

2021

Link zum Volltext

Verfügbarkeit prüfen

Collective Attention and Collective Intelligence: The Role of Hierarchy and Team Gender Composition

Organization science (Providence, R.I.), 2023-05, Vol.34 (3), p.1315-1331

2023

Link zum Volltext

Verfügbarkeit prüfen

Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data

The Lancet (British edition), 2015-04, Vol.385 (9975), p.1305-1314

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

The Lancet (British edition), 2021-09, Vol.398 (10303), p.856-869

2021

Link zum Volltext

Verfügbarkeit prüfen

Emergency department treatments and physiotherapy for acute whiplash: a pragmatic, two-step, randomised controlled trial

The Lancet (British edition), 2013-02, Vol.381 (9866), p.546-556

2013

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022

American journal of public health (1971), 2023-01, Vol.113 (1), p.96-104

2023

Link zum Volltext

Verfügbarkeit prüfen

Older Jail Inmates and Community Acute Care Use

American journal of public health (1971), 2014-09, Vol.104 (9), p.1728-1733

2014

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

The Lancet (British edition), 2020-12, Vol.396 (10265), p.1817-1828

2020

Link zum Volltext

Verfügbarkeit prüfen

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2019-07, Vol.394 (10193), p.121-130

2019

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-01, Vol.393 (10167), p.156-167

2019

Link zum Volltext

Verfügbarkeit prüfen

Closing the gap in a generation: health equity through action on the social determinants of health

The Lancet (British edition), 2008-11, Vol.372 (9650), p.1661-1669

2008

Link zum Volltext

Verfügbarkeit prüfen

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

The Lancet (British edition), 2019-07, Vol.394 (10193), p.131-138

2019

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10117), p.219-229

2018

Link zum Volltext

Verfügbarkeit prüfen

HIV Testing, Access to HIV-Related Services, and Late-Stage HIV Diagnoses Across US States, 2013-2016

American journal of public health (1971), 2019-11, Vol.109 (11), p.1589-1595

2019

Link zum Volltext

Verfügbarkeit prüfen

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

The Lancet (British edition), 2019-12, Vol.394 (10216), p.2263-2270

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Culture and health

Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial

Racism and the Life Course: Taking Time Seriously

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Collective Attention and Collective Intelligence: The Role of Hierarchy and Team Gender Composition

Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Emergency department treatments and physiotherapy for acute whiplash: a pragmatic, two-step, randomised controlled trial

SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022

Older Jail Inmates and Community Acute Care Use

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Closing the gap in a generation: health equity through action on the social determinants of health

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

HIV Testing, Access to HIV-Related Services, and Late-Stage HIV Diagnoses Across US States, 2013-2016

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Aktive Filter

Suchergebnisse filtern